Home
About Us
About Us
Industry Recognition
Experts
Milestones
Platforms
SolnAb™
SolnNuc™
SolnZyme™
SolnCell™
SolnMat™
Solutions
Metabolic Disease Therapeutics
Musculoskeletal Regeneration
Regenerative Biomaterials
Smart Health Management
Ecosystem
Ecosystem
Partners
Technologies
Products
News
Contact
Contact
Careers
Message
中文
Position:
Home
>
About Us
>
Milestones
>
2024
2024
All
Established AI-driven de novo antibody discovery platform and R&D system.
2026-07-22
More >>
Developed AI-assisted biomaterial design platform.
2026-07-22
More >>
Founded Aiprui Biotechnology, focusing on advanced biomaterials and medical aesthetics & wellness.
2026-07-22
More >>
Incubated Wiselytics Intelligent Technology, focusing on neuromodulation and electrical stimulation R&D.
2026-07-22
More >>
Recognized as "Zhejiang Provincial Science & Technology SME."
2026-07-22
More >>
1